- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Chris Belmont Responds to How Big Data Is Improving Adherence and Reducing Admissions
Chris Belmont, vice president and chief information officer, MD Anderson Cancer Center, says that health systems like Ochsner are using data to validate what they already know about certain patient cases.
Chris Belmont, vice president and chief information officer, MD Anderson Cancer Center, says that health systems like Ochsner are using data to validate what they already know about certain patient cases.
“For example, we’re monitoring patients in their home, so we’re providing them with devices so that we can stay connected with them after they leave. We know things that occur in the first 7 days, or actually first 14 days, are one of the big the reasons for readmissions,” says Mr Belmont. “The typical approach was to have someone—say from Home Health or someone call them and monitor them—but now we have devices that are collecting data more frequently.”
Mr Belmont suggests that instead of having someone manually go out to take patient information every few days, health systems can electronically “visit” patients as often as desired. For those patients managing chronic conditions such as high blood pressure, or health issues like obesity, electronic health monitoring can be more convenient.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Reduced Rehospitalizations and Potential Cost Savings With Orca-T for Acute Leukemia, MDS
April 11th 2025Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
Survey Finds Slow Start on CMS Interoperability Rule Implementation
April 10th 2025With deadlines looming in 2026 and 2027 for compliance with the CMS Advancing Interoperability and Improving Prior Authorization Final Rule, a survey indicates a concerning lack of readiness among payers and providers to meet the new requirements for data sharing.
Read More
